AB
AERI

Amalgamated Bank’s Aerie Pharmaceuticals AERI Stock Holding History

Amalgamated Bank’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,370
Closed -$112K – 2985
2022
Q3 		$112K Buy
7,370
+170
+2% +$1.98K ﹤0.01% 2101
2022
Q2 		$54K Buy
7,200
+286
+4% +$2.02K ﹤0.01% 2443
2022
Q1 		$63K Buy
+6,914
New +$53.3K ﹤0.01% 2366
2019
Q3 		– Sell
-7,596
Closed -$224K – 1800
2019
Q2 		$224K Buy
7,596
+2,205
+41% +$85K 0.01% 1521
2019
Q1 		$256K Buy
+5,391
New +$237K 0.01% 1358
2018
Q3 		– Sell
-5,441
Closed -$368K – 1658
2018
Q2 		$368K Buy
5,441
+906
+20% +$50.7K 0.01% 1194
2018
Q1 		$246K Buy
4,535
+63
+1% +$3.52K 0.01% 1337
2017
Q4 		$267K Buy
4,472
+286
+7% +$17.3K 0.01% 1323
2017
Q3 		$203K Buy
4,186
+299
+8% +$16.3K 0.01% 1437
2017
Q2 		$204K Buy
+3,887
New +$181K 0.01% 1438

Amalgamated Bank's AERI Position: Q4 2022 in Review

Amalgamated Bank sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 7,370 shares — an estimated $112K sold.

Amalgamated Bank first reported a position in AERI in Q2 2017 and held it in 10 quarters. The position peaked at $368K in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Amalgamated Bank reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Amalgamated Bank sold 7,370 Aerie Pharmaceuticals shares in Q4 2022, an estimated $112K.
  • Amalgamated Bank first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 10 quarters.
  • Amalgamated Bank's Aerie Pharmaceuticals position peaked at $368K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Amalgamated Bank's 13F filing for Q4 2022, filed 10 Feb 2023.